Quick Links

Accreditation/Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


PER Pulse™ Recaps highlight key elements of the Oncology Briefings: Updates in Therapeutic Options and Approaches for Tenosynovial Giant Cell Tumors online CME activity.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Jazz Pharmaceuticals, Inc.

Oncology Briefings™: Updates in Pediatric Hepatic Veno-Occlusive Disease: Integrating Novel Therapeutic Strategies to Overcome Post-Transplant Obstacles

Release Date: May 31, 2017
Expiration Date: May 31, 2018
Media: Internet - based


Activity Overview

This interactive monograph includes an overview of diagnostic and management strategies for pediatric hepatic veno-occlusive disease (VOD), a serious complication that can occur in patients who undergo hematopoietic stem cell transplantation or other medical interventions. Additional content includes a review of recent data regarding therapeutic approaches for VOD. The activity features audio commentary from a key thought leader that addresses salient points from clinical evidence and pearls for clinical practice.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Jazz Pharmaceuticals, Inc.

CME Activity Table of Contents

  • Diagnosis of and Risk Factors for Veno-Occlusive Disease
  • VOD Risk Stratification and Data Pertaining to the Use of Prophylaxis
  • Treatment Approaches and Counseling Strategies for Patients with VOD

Instructions for This Activity and Receiving Credit

  • You will need to log in to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review audio files/content until you finish the presentation.
  • At the end of the activity, "Educational Content/Audio Files" will be available for your reference.
  • In order to receive a CME certificate, participants must complete the activity.
  • Complete the Posttest and pass with a score of 70% or higher, complete the Evaluation, and then click on “Request for Credit.” Participants may immediately download a CME certificate upon completion of these steps.

Target Audience

This activity is directed toward medical oncologists and hematologists who treat pediatric patients with hepatic veno-occlusive disease. Fellows, nurses, nurse practitioners, physician assistants, and other healthcare professionals involved in the management of patients with cancer are also invited to participate.

Learning Objectives

At the conclusion of this activity, you should be better prepared to:

  1. Discuss the risk factors of veno-occlusive disease (VOD) and strategies for early detection
  2. Identify recent advances in the management of VOD, including clinical trial data supporting prophylactic measures
  3. Discuss recent clinical trial findings concerning the novel compound for patients with VOD
  4. Discuss recent clinical trial evidence in the context of evolving treatment paradigms in the management of patients with VOD

Faculty, Staff, and Planners' Disclosures


Stephan A. Grupp, MD, PhD
Director, Cancer Immunotherapy Frontier Program
CCCR Director of Translational Research
Children's Hospital of Philadelphia
Philadelphia, PA

Disclosure: Consultant: Jazz Pharmaceuticals

The staff of Physicians' Education Resource®, LLC have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical and nursing education purposes only, and is not meant to substitute for the independent clinical judgment of a physician relative to diagnostic or treatment options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER®.

Become a Member

Forgot Password?
Calendar of Events
Filter By